Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center
Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center
New York, New York, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) | Advanced Solid Tumor; Immune-related Adverse Events | Active, not recruiting | Phase 2 | 2026-08-03 | NCT04375228 |